fda tirzepatide shortage list says compounding pharmacies can keep making weight-loss med tirzepatide, for now GLP-1 Drugs: FDA Removes Lilly's

Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist: a pilot study

Distinguishing harmless sensations from warning signs Normal post-injection feelings include a small sting, slight warmth, or faint tingling that resolves quickly

Like other GLP-1 medications, the most common side effects include nausea, constipation, and decreased appetite

Maintaining a balanced diet can help reduce this effect

This becomes especially important if you experience any diarrhea episodes, which can occur alongside or alternating with constipation during the adjustment period